Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Stitch Fix Inc (SFIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Stitch Fix Inc — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while Stitch Fix Inc trades at $2.84 (market cap $366.07M). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 34.4× Stitch Fix Inc's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Stitch Fix Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Stitch Fix Inc for 31 Days on average.
| HALO | SFIX | |
|---|---|---|
Market Cap | $12.58B | $366.07M |
Volume | 2,179,278 | 5,152,008 |
Sector | Health | Consumer Cyclical |
52-Week High | $115.22 | $5.64 |
52-Week Low | $61.63 | $2.16 |
Typical Hold Time | 1 Days | 31 Days |
Enterprise Value | $14.49B | $261.88M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Stitch Fix (SFIX) trades at $2.73, showing no change in the latest session. The stock faces bearish technical signals with recent earnings beats overshadowed by weak forward guidance. Revenue has stabilized around $1.3 billion, but profitability remains elusive with negative net income margins. Recent news highlights multiple law firm investigations and a significant post-earnings decline due to cautious fiscal 2027 outlook.
The outlook remains challenging with Wall Street showing cautious sentiment (24% buy ratings). While AI initiatives show promise for customer engagement, declining active clients and ongoing profitability concerns present significant headwinds. The consensus price target of $3.40 suggests limited upside potential amid execution risks and competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Stitch Fix Inc
Stitch Fix Inc offers personal style service for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandises with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types and price points including Women's, Petite, Maternity, Men's and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry and handbags, and sells merchandise across various range of price points.
Read more on SFIX →
